Form D · Biotechnology
B4CC, Inc.
Gainesville, GA · CIK 0001660721
Offering snapshot reported May 20, 2020 · SEC filing
- Reported sold
- $150K Offering amount: $1.5M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 5, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 20, 2020 | Initial | $150,000 | No comparison | 3 | SEC filing |
| Nov 28, 2017 | Initial | $560,000 | No comparison | 8 | SEC filing |
| Dec 13, 2016 | Amendment | $1,672,500 | $757,500vs May 16, 2016 | 26 | SEC filing |
| May 16, 2016 | Initial | $915,000 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-367399
Source: Form D, filed May 20, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brian Campbell | Executive |
| Patrick K. De Grouchy | Executive |
| Ken Dixon | Director, Executive, Promoter |
| Ben Dyer | Executive |
| Jim Mathis | Director |
| Danny Scroggs | Director |
| Ronnie Whitmire, Md | Director |
| Ronnie Whitmire, M.D. | Director |
| Robert Willis, Jr. | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
999 Chestnut Street Suite 20
Gainesville, GA, 30501
Gainesville, GA, 30501